Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 733-735, October 2007

The future of SPECT in a time of PET

  • Floris P. Jansen

      Affiliations

    • Functional Imaging Lab, KW-C702, GE Research, Niskayuna, NY 12309, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 518 387 6533.
  • ,
  • Jean-Luc Vanderheyden

      Affiliations

    • Technology and Medical Office, GE Healthcare, Waukesha, WI 53188, USA

Received 22 June 2007; accepted 25 June 2007. published online 03 September 2007.

Abstract 

As positron emission tomography (PET) imaging is becoming more prevalent in clinical practice, it is reasonable to ask if there will be a role for single photon emission computed tomography (SPECT) in the future. This article considers that question, focusing on areas where SPECT can differentiate itself from PET for fundamental reasons: breadth of available radionuclides, simultaneous imaging of multiple agents, cost-effectiveness and adaptability to specific imaging situations. The conclusion is that SPECT will continue to evolve and exist alongside PET and will grow the field of molecular imaging with improved efficiency and patient workflow.

Keywords: SPECT, Sensitivity, Resolution, CZT, Detector technology, Molecular imaging

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0969-8051(07)00173-4

doi:10.1016/j.nucmedbio.2007.06.013

Nuclear Medicine and Biology
Volume 34, Issue 7 , Pages 733-735, October 2007